​

Erasca (ERAS) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ERAS Stock Forecast

Erasca (ERAS) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $17.50, with a high of $30.00 and a low of $10.00. This represents a -5.25% decline from the last price of $18.47.

- $6 $12 $18 $24 $30 High: $30 Avg: $17.5 Low: $10 Last Closed Price: $18.47

ERAS Stock Rating

Erasca stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (81.82%), 2 Hold (18.18%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 2 9 Strong Sell Sell Hold Buy Strong Buy

ERAS Price Target Upside V Benchmarks

TypeNameUpside
StockErasca-5.25%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts1313
Avg Price Target$16.00$24.00$12.23
Last Closing Price$18.47$18.47$18.47
Upside/Downside-13.37%29.94%-33.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26262--10
Jun, 26261-110
May, 26261-110
Apr, 26261-110
Mar, 26261-110
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 04, 2026Wolfe Research$16.00$13.1821.40%-13.37%
May 12, 2026Mizuho Securities$26.00$10.44149.04%40.77%
Apr 27, 2026Stifel Nicolaus$30.00$21.5039.53%62.43%
Mar 10, 2026Laura PrendergastStifel Nicolaus$20.00$15.5828.37%8.28%
Jan 27, 2026Guggenheim$12.00$9.6124.87%-35.03%
Jan 26, 2026Sean LaamanMorgan Stanley$10.00$9.960.40%-45.86%
Jan 16, 2026Piper Sandler$11.00$9.5615.06%-40.44%
Jan 12, 2026Laura PrendergastStifel Nicolaus$10.00$6.2360.51%-45.86%
Jan 08, 2026Morgan Stanley$4.00$5.17-22.63%-78.34%
Jan 07, 2026Piper Sandler$5.00$3.6337.74%-72.93%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 04, 2026Bank of America SecuritiesNeutralupgrade
Mar 13, 2026CitigroupBuyBuyhold
Jan 27, 2026GuggenheimBuyBuyhold
Jan 16, 2026Piper SandlerOverweightOverweighthold
Jan 07, 2026Piper SandlerOverweightinitialise
May 14, 2025GuggenheimBuyBuyhold
Mar 26, 2025Raymond JamesOutperforminitialise
Nov 18, 2024JefferiesBuyinitialise
Aug 13, 2024H.C. WainwrightBuyBuyhold
May 20, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.83$-0.69$-0.44---
Avg Forecast$-0.91$-0.74$-0.60$-0.64$-0.65$-0.54
High Forecast$-0.79$-0.70$-0.46$-0.52$-0.50$-0.54
Low Forecast$-1.20$-0.85$-0.72$-0.77$-0.76$-0.54
Surprise %-8.79%-6.76%-26.67%---

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$817.84K$4.53M$26.59M$97.80M
High Forecast--$817.84K$4.53M$26.59M$97.80M
Low Forecast--$817.84K$4.53M$26.59M$97.80M
Surprise %------

Net Income Forecast

$-200M $-170M $-140M $-110M $-80M $-50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-125.04M$-161.65M$-124.55M---
Avg Forecast$-125.04M$-116.45M$-89.15M$-96.58M$-94.19M$-81.10M
High Forecast$-118.21M$-105.04M$-69.83M$-78.11M$-74.48M$-81.10M
Low Forecast$-180.19M$-127.87M$-108.47M$-115.04M$-113.91M$-81.10M
Surprise %-38.81%39.70%---

ERAS Forecast FAQ

Is Erasca stock a buy?

Erasca stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Erasca is a favorable investment for most analysts.

What is Erasca's price target?

Erasca's price target, set by 11 Wall Street analysts, averages $17.5 over the next 12 months. The price target range spans from $10 at the low end to $30 at the high end, suggesting a potential -5.25% change from the previous closing price of $18.47.

How does Erasca stock forecast compare to its benchmarks?

Erasca's stock forecast shows a -5.25% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Erasca over the past three months?

  • July 2026: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 20.00% Strong Buy, 60.00% Buy, 10.00% Hold, 0% Sell, 10.00% Strong Sell.
  • May 2026: 20.00% Strong Buy, 60.00% Buy, 10.00% Hold, 0% Sell, 10.00% Strong Sell.

What is Erasca’s EPS forecast?

Erasca's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.64, marking a 45.45% increase from the reported $-0.44 in 2025. Estimates for the following years are $-0.65 in 2027, and $-0.54 in 2028.

What is Erasca’s revenue forecast?

Erasca's average annual revenue forecast for its fiscal year ending in December 2026 is $4.53M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $26.59M, and $97.8M for 2028.

What is Erasca’s net income forecast?

Erasca's net income forecast for the fiscal year ending in December 2026 stands at $-96.578M, representing a -22.46% decrease from the reported $-125M in 2025. Projections indicate $-94.193M in 2027, and $-81.1M in 2028.